NTRBW

Nutriband Inc. Warrant
NASDAQ

Key Statistics

Market Cap
P/E Ratio
EPS
$-0.51
Beta
1.94
52W High
$2.99
52W Low
$0.77
50-Day MA
$1.11
200-Day MA
$1.46
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About Nutriband Inc. Warrant

Nutraband Inc. Warrant (NTRBW) offers a unique investment opportunity tied to Nutriband Inc., a forward-thinking biotechnology company specializing in advanced transdermal drug delivery systems. Focused on innovative solutions for pain management and addiction treatment, Nutriband boasts a robust pipeline designed to meet significant healthcare needs. With proprietary technologies and a strategic vision aimed at leveraging growth in the pharmaceutical sector, Nutriband is strategically positioned to attract institutional investors seeking exposure to cutting-edge biotech advancements.

Official WebsiteUSAFY End: January

Fundamentals

Revenue (TTM)$1.80M
Gross Profit (TTM)511,130
EBITDA$-7.99M
Operating Margin-289.40%
Return on Equity-145.70%
Return on Assets-78.20%
Revenue/Share (TTM)$0.15
Book Value$0.49
Price-to-Book
Price-to-Sales (TTM)
EV/Revenue-
EV/EBITDA
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-35.10%
Shares Outstanding0
Float$5.28M
% Insiders0.00%
% Institutions0.00%

Historical Volatility

HV 10-Day
216.45%
HV 20-Day
184.99%
HV 30-Day
163.72%
HV 60-Day
145.64%
HV Rank

Volatility is currently expanding

Latest News

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Nutriband's Active Intelligence subsidiary to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference Company to Meet with Buyers from Walmart Inc, Walgreens, Amazon.com, Inc., Cardinal Health and Other Major National Retailers ORLANDO, Fla., May 15, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) and its wholly owned subsidiary Active Intelligence (“Active Intelligence” or the “Company”), an emerging leader in innovative wellness, recovery, and performance-focused consumer products, today announced its participation in the upcoming ECRM conference taking place in June 2026, where the Company will showcase its latest AI-branded product portfolio to buyers and executives from some of the nation's largest retail and healthcare organizations.

GlobeNewsWire5/15/2026Neutral
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

ORLANDO, Fla., April 22, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan has featured on the latest episode of the Jack Neel Podcast to discuss the opioid crisis, the Company's AVERSA technology and the opportunity for Nutriband to improve the safety profile of easily abused medications.

GlobeNewsWire4/22/2026Neutral
Data last updated: 7/9/2026